
Bloomberg Businessweek
Fed Needs to Forget About Inflation and Focus on Jobs
Nov 8, 2023
Jeff Jones, CEO of H&R Block, discusses earnings for the tax prep company and their take on Middle America. Angela Stent, Senior Fellow at Brookings Institution, shares her thoughts on how the Israel-Hamas war could impact the war between Russia and Ukraine. Bloomberg Businessweek Editor Joel Weber and Businessweek Features Writer Ashlee Vance provide the details of Ashlee's Businessweek Magazine cover story Elon Musk’s Brain Implant Startup Is About to Start Cutting.
51:33
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Neuralink, led by Elon Musk, is preparing for its first clinical trial for brain implants in humans, offering promising potential for improving communication and movement for individuals with dire circumstances.
- Leo Kelly, CEO of Verdon's Capital Advisors, predicts that the Federal Reserve will resume its tightening policy in the future due to persistent inflation and a significant amount of money still in the system, advising caution in investing and waiting for potential buying opportunities in the future.
Deep dives
Neuralink Prepares for First Clinical Trial of Brain Implants
Neuralink, the company led by Elon Musk, is gearing up for its first clinical trial to implant devices in humans. The company has received FDA approval and plans to start the trials soon. Neuralink's brain implants are more powerful and smaller than those of other competitors in the field. The company aims to provide a solution for individuals with dire circumstances such as paralysis, strokes, and ALS. While the technology is still in its early stages, there is great promise for improving communication and movement for those in need. The market for brain implants is growing, with hundreds of millions of dollars being invested in the field.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.